| Literature DB >> 26855805 |
Sergiy Vozianov1, Maxim Sabadash1, Alexander Shulyak1.
Abstract
INTRODUCTION: The ren is considered as the most commonly damaged genitourinary organ. In general, blunt kidney traumas (BKT) are mild and can be managed conservatively. We aimed to analyze our own experiences of selective renal artery embolization (RAE) in BKT patients and compare obtained results with other reports.Entities:
Keywords: blunt kidney trauma; hematuria; renal artery embolization
Year: 2015 PMID: 26855805 PMCID: PMC4742433 DOI: 10.5173/ceju.2015.491
Source DB: PubMed Journal: Cent European J Urol ISSN: 2080-4806
Figure 1The catheter was inserted transfemorally into renal artery closely to ruptured branch.
Figure 2The angiogram evaluated source of bleeding (arrow).
Figure 3Embolization of ruptured vessel.
Figure 4Final image of arterial angiography at the end of the RAE with pointing of devascularized area.
Medical and technical complications of RAE
| Complications | Technical | Medical | TOTAL (events) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accidental embolization of unruptured arteria | Puncture-site bleeding | Short-term | Long-term | ||||||||
| Postembolization syndrome | Decrease in renal function | Arterial hypertension | Repeated persistent gross hematuria | Decrease in renal function | Renal abscess | Arterial hypertension | |||||
| n | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 15 | |
| % | 10.0 | 5.0 | 10.0 | 5.0 | 10.0 | 10.0 | 10.0 | 5.0 | 10.0 | ||
Means of TMAX and T1/2 in damaged kidneys calculated after radioisotope renography
| Variables | M ±SD | p | ||
|---|---|---|---|---|
| 3rd month | 6th month | 12th month | ||
| TMAX, min | 11.32 ±1.67 | 7.51 ±0,53 | 6.12 ±0.47 | <0.05 |
| T1/2, min | 24.33 ±3.04 | 16.31 ±2.38 | 12.25 ±1.43 | <0.05 |
Studies of RAE efficacy and success rates
| Study | N | AAST grades | Reembolization rate (%) | Renal salvage rate (%) |
|---|---|---|---|---|
| Breyer et al. [ | 10 | IV | – | 100 |
| Dinkel et al. [ | 9 | III-V | – | 100 |
| van der Wilden et al. [ | 25 | IV-V | – | 90.3 |
| Rao et al. [ | 16 | III-V | – | 100 |
| Our | 20 | II-IV | 10.0 | 100 |
N – number of patients